Evidence map›Paper›PMID 35741740›Full record

ReviewGenes2022

Stroke and Etiopathogenesis: What Is Known?

Tiziana Ciarambino, Pietro Crispino, Erika Mastrolorenzo, Antonello Viceconti, Mauro Giordano

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Epigenetics as a target to mitigate excess stroke risk in people of African ancestry: A scoping review.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Tiziana CiarambinoInternal Medicine Department, Hospital of Marcianise, ASL Caserta, 81031 Caserta, Italy.
Pietro CrispinoEmergency Department, Hospital of Latina, ASL Latina, 04100 Latina, Italy.ORCID 0000-0002-3917-1478
Erika MastrolorenzoDistretto Sanitario Lauria, ASP Basilicata, 85044 Lauria, Italy.
Antonello VicecontiEmergency Unit, San Giovanni Hospital, AOR San Carlo, 85042 Lagonegro, Italy.
Mauro GiordanoDepartment of Advanced Medical and Surgical Sciences, University of Campania "L. Vanvitelli", 80138 Naples, Italy.ORCID 0000-0001-8175-547X
Ospedale San Carlo · ITOspedale Santa Maria Goretti · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA substantial portion of stroke risk remains unexplained, and a contribution from genetic factors is supported by recent findings. In most cases, genetic risk factors contribute to stroke risk as part of a multifactorial predisposition. A major challenge in identifying the genetic determinants of stroke is fully understanding the complexity of the phenotype.

aimsOur narrative review is needed to improve our understanding of the biological pathways underlying the disease and, through this understanding, to accelerate the identification of new drug targets.

methodsWe report, the research in the literature until February 2022 in this narrative review. The keywords are stroke, causes, etiopathogenesis, genetic, epigenetic, ischemic stroke.

resultsWhile better risk prediction also remains a long-term goal, its implementation is still complex given the small effect-size of genetic risk variants. Some authors encourage the use of stroke genetic panels for stroke risk assessment and further stroke research. In addition, new biomarkers for the genetic causes of stroke and new targets for gene therapy are on the horizon.

conclusionWe summarize the latest evidence and perspectives of ischemic stroke genetics that may be of interest to the physician and useful for day-to-day clinical work in terms of both prevention and treatment of ischemic stroke.

Indexed as

Ischemic StrokeStrokeGenetic Predisposition to DiseaseHumansPhenotypeRisk Factorscausesepigeneticetiopathogenesisgeneticischemic strokestroke

Identifiers

PMID35741740
PMCPMC9222702
OpenAlexW4281753554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.